Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 99

1.

Genetic association analysis with pedigrees: Direct inference using the composite likelihood ratio.

Baskurt Z, Strug LJ.

Genet Epidemiol. 2018 Sep 17. doi: 10.1002/gepi.22153. [Epub ahead of print]

PMID:
30221395
2.

Visceral fat-related systemic inflammation and the adolescent brain: a mediating role of circulating glycerophosphocholines.

Syme C, Pelletier S, Shin J, Abrahamowicz M, Leonard G, Perron M, Richer L, Veillette S, Gaudet D, Pike B, Strug LJ, Wang Y, Xu H, Taylor G, Bennett S, Paus T, Pausova Z.

Int J Obes (Lond). 2018 Sep 11. doi: 10.1038/s41366-018-0202-2. [Epub ahead of print]

PMID:
30206338
3.

SLC26A9 Gene Is Associated With Lung Function Response to Ivacaftor in Patients With Cystic Fibrosis.

Corvol H, Mésinèle J, Douksieh IH, Strug LJ, Boëlle PY, Guillot L.

Front Pharmacol. 2018 Jul 26;9:828. doi: 10.3389/fphar.2018.00828. eCollection 2018.

4.

The evidential statistical paradigm in genetics.

Strug LJ.

Genet Epidemiol. 2018 Aug 18. doi: 10.1002/gepi.22151. [Epub ahead of print] Review.

PMID:
30120797
5.

Recent advances in developing therapeutics for cystic fibrosis.

Strug LJ, Stephenson AL, Panjwani N, Harris A.

Hum Mol Genet. 2018 Aug 1;27(R2):R173-R186. doi: 10.1093/hmg/ddy188.

PMID:
30060192
6.

AGTR2 absence or antagonism prevents cystic fibrosis pulmonary manifestations.

Darrah RJ, Jacono FJ, Joshi N, Mitchell AL, Sattar A, Campanaro CK, Litman P, Frey J, Nethery DE, Barbato ES, Hodges CA, Corvol H, Cutting GR, Knowles MR, Strug LJ, Drumm ML.

J Cyst Fibros. 2018 Jun 21. pii: S1569-1993(18)30618-0. doi: 10.1016/j.jcf.2018.05.013. [Epub ahead of print]

7.

Testing Calibration of Cox Survival Models at Extremes of Event Risk.

Soave DM, Strug LJ.

Front Genet. 2018 May 22;9:177. doi: 10.3389/fgene.2018.00177. eCollection 2018.

8.

The CF Canada-Sick Kids Program in individual CF therapy: A resource for the advancement of personalized medicine in CF.

Eckford PDW, McCormack J, Munsie L, He G, Stanojevic S, Pereira SL, Ho K, Avolio J, Bartlett C, Yang JY, Wong AP, Wellhauser L, Huan LJ, Jiang JX, Ouyang H, Du K, Klingel M, Kyriakopoulou L, Gonska T, Moraes TJ, Strug LJ, Rossant J, Ratjen F, Bear CE.

J Cyst Fibros. 2018 Apr 20. pii: S1569-1993(18)30086-9. doi: 10.1016/j.jcf.2018.03.013. [Epub ahead of print]

PMID:
29685812
9.

Improving imputation in disease-relevant regions: lessons from cystic fibrosis.

Panjwani N, Xiao B, Xu L, Gong J, Keenan K, Lin F, He G, Baskurt Z, Kim S, Zhang L, Esmaeili M, Blackman S, Scherer SW, Corvol H, Drumm M, Knowles M, Cutting G, Rommens JM, Sun L, Strug LJ.

NPJ Genom Med. 2018 Mar 20;3:8. doi: 10.1038/s41525-018-0047-6. eCollection 2018.

10.

Reference percentiles of FEV1 for the Canadian cystic fibrosis population: comparisons across time and countries.

Kim SO, Corey M, Stephenson AL, Strug LJ.

Thorax. 2018 May;73(5):446-450. doi: 10.1136/thoraxjnl-2017-210899. Epub 2018 Feb 6.

PMID:
29434047
11.

The Personal Genome Project Canada: findings from whole genome sequences of the inaugural 56 participants.

Reuter MS, Walker S, Thiruvahindrapuram B, Whitney J, Cohn I, Sondheimer N, Yuen RKC, Trost B, Paton TA, Pereira SL, Herbrick JA, Wintle RF, Merico D, Howe J, MacDonald JR, Lu C, Nalpathamkalam T, Sung WWL, Wang Z, Patel RV, Pellecchia G, Wei J, Strug LJ, Bell S, Kellam B, Mahtani MM, Bassett AS, Bombard Y, Weksberg R, Shuman C, Cohn RD, Stavropoulos DJ, Bowdin S, Hildebrandt MR, Wei W, Romm A, Pasceri P, Ellis J, Ray P, Meyn MS, Monfared N, Hosseini SM, Joseph-George AM, Keeley FW, Cook RA, Fiume M, Lee HC, Marshall CR, Davies J, Hazell A, Buchanan JA, Szego MJ, Scherer SW.

CMAJ. 2018 Feb 5;190(5):E126-E136. doi: 10.1503/cmaj.171151.

12.

Translational research to enable personalized treatment of cystic fibrosis.

Hagemeijer MC, Siegwart DJ, Strug LJ, Cebotaru L, Torres MJ, Sofoluwe A, Beekman JM.

J Cyst Fibros. 2018 Mar;17(2S):S46-S51. doi: 10.1016/j.jcf.2017.10.017. Epub 2017 Dec 21. Review.

PMID:
29275953
13.

Airway Mucosal Host Defense Is Key to Genomic Regulation of Cystic Fibrosis Lung Disease Severity.

Polineni D, Dang H, Gallins PJ, Jones LC, Pace RG, Stonebraker JR, Commander LA, Krenicky JE, Zhou YH, Corvol H, Cutting GR, Drumm ML, Strug LJ, Boyle MP, Durie PR, Chmiel JF, Zou F, Wright FA, O'Neal WK, Knowles MR.

Am J Respir Crit Care Med. 2018 Jan 1;197(1):79-93. doi: 10.1164/rccm.201701-0134OC.

PMID:
28853905
14.

Corrigendum: Novel variation at chr11p13 associated with cystic fibrosis lung disease severity.

Dang H, Gallins PJ, Pace RG, Guo XL, Stonebraker JR, Corvol H, Cutting GR, Drumm ML, Strug LJ, Knowles MR, O'Neal WK.

Hum Genome Var. 2017 May 25;4:17016. doi: 10.1038/hgv.2017.16. eCollection 2017.

15.

Don't judge a book by its cover: the emerging challenge of diagnosing CF in non-Caucasians.

Chin M, Strug L, Stephenson AL.

J Cyst Fibros. 2017 Jul;16(4):439-440. doi: 10.1016/j.jcf.2017.05.007. Epub 2017 Jun 7. No abstract available.

PMID:
28599956
16.

Leveraging cell type specific regulatory regions to detect SNPs associated with tissue factor pathway inhibitor plasma levels.

Dennis J, Medina-Rivera A, Truong V, Antounians L, Zwingerman N, Carrasco G, Strug L, Wells P, Trégouët DA, Morange PE, Wilson MD, Gagnon F.

Genet Epidemiol. 2017 Jul;41(5):455-466. doi: 10.1002/gepi.22049. Epub 2017 Apr 18.

PMID:
28421636
17.

Reply to: Is a microRNA-328 binding site in PAX6 associated with Rolandic epilepsy?

Strug LJ, Pal DK.

Ann Clin Transl Neurol. 2017 Mar 23;4(4):278-280. doi: 10.1002/acn3.403. eCollection 2017 Apr. No abstract available.

18.

Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder.

C Yuen RK, Merico D, Bookman M, L Howe J, Thiruvahindrapuram B, Patel RV, Whitney J, Deflaux N, Bingham J, Wang Z, Pellecchia G, Buchanan JA, Walker S, Marshall CR, Uddin M, Zarrei M, Deneault E, D'Abate L, Chan AJ, Koyanagi S, Paton T, Pereira SL, Hoang N, Engchuan W, Higginbotham EJ, Ho K, Lamoureux S, Li W, MacDonald JR, Nalpathamkalam T, Sung WW, Tsoi FJ, Wei J, Xu L, Tasse AM, Kirby E, Van Etten W, Twigger S, Roberts W, Drmic I, Jilderda S, Modi BM, Kellam B, Szego M, Cytrynbaum C, Weksberg R, Zwaigenbaum L, Woodbury-Smith M, Brian J, Senman L, Iaboni A, Doyle-Thomas K, Thompson A, Chrysler C, Leef J, Savion-Lemieux T, Smith IM, Liu X, Nicolson R, Seifer V, Fedele A, Cook EH, Dager S, Estes A, Gallagher L, Malow BA, Parr JR, Spence SJ, Vorstman J, Frey BJ, Robinson JT, Strug LJ, Fernandez BA, Elsabbagh M, Carter MT, Hallmayer J, Knoppers BM, Anagnostou E, Szatmari P, Ring RH, Glazer D, Pletcher MT, Scherer SW.

Nat Neurosci. 2017 Apr;20(4):602-611. doi: 10.1038/nn.4524. Epub 2017 Mar 6.

19.

Cystic fibrosis gene modifier SLC26A9 modulates airway response to CFTR-directed therapeutics.

Strug LJ, Gonska T, He G, Keenan K, Ip W, Boëlle PY, Lin F, Panjwani N, Gong J, Li W, Soave D, Xiao B, Tullis E, Rabin H, Parkins MD, Price A, Zuberbuhler PC, Corvol H, Ratjen F, Sun L, Bear CE, Rommens JM.

Hum Mol Genet. 2016 Oct 15;25(20):4590-4600. doi: 10.1093/hmg/ddw290.

20.

Endoplasmic Reticulum Stress and Chemokine Production in Cystic Fibrosis Airway Cells: Regulation by STAT3 Modulation.

Tang AC, Saferali A, He G, Sandford AJ, Strug LJ, Turvey SE.

J Infect Dis. 2017 Jan 15;215(2):293-302. doi: 10.1093/infdis/jiw516.

PMID:
27799352

Supplemental Content

Support Center